Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

atai Life Sciences stock logo

1. atai Life Sciences NASDAQ:ATAI

$3.23 +0.44 (+15.77%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.32 +0.09 (+2.79%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$647.09 million
P/E Ratio
-3.55
Consensus Rating
Strong Buy
Consensus Price Target
$9.00 (+178.6% Upside)
Volume
14.88 million shares
Average Volume
2.19 million shares
Telecom Italia stock logo

2. Telecom Italia OTCMKTS:TIIAY

$4.68 +0.02 (+0.43%)
As of 07/18/2025 03:50 PM Eastern

Telecom Italia S.p.A., together with its subsidiaries, engages in the provision of fixed and mobile telecommunications services in Italy and internationally. More about Telecom Italia

Consensus Rating
Buy
Volume
3,353 shares
Average Volume
10,551 shares
Today's Range
$4.68
$4.70
50-Day Range
$3.96
$4.90
52-Week Range
$2.19
$4.90
OS Therapies stock logo

3. OS Therapies NYSE:OSTX

$1.64 -0.04 (-2.38%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.67 +0.03 (+2.07%)
As of 07/18/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$46.08 million
P/E Ratio
-1.91
Consensus Rating
Buy
Consensus Price Target
$18.00 (+997.6% Upside)
Volume
348,131 shares
Average Volume
488,762 shares
TuHURA Biosciences stock logo

4. TuHURA Biosciences NASDAQ:HURA

$2.62 +0.09 (+3.56%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.61 -0.01 (-0.38%)
As of 07/18/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$114.44 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+383.5% Upside)
Volume
348,645 shares
Average Volume
262,411 shares
Today's Range
$2.53
$2.73
zSpace stock logo

5. zSpace NASDAQ:ZSPC

$2.78 0.00 (0.00%)
As of 07/18/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$63.61 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+439.6% Upside)
Volume
52,774 shares
Average Volume
62,074 shares
Today's Range
$2.69
$2.83
Beyond Air stock logo

6. Beyond Air NASDAQ:XAIR

$3.26 +0.02 (+0.62%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.32 +0.06 (+1.84%)
As of 07/18/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. More about Beyond Air

Market Capitalization
$14.08 million
P/E Ratio
-0.21
Consensus Rating
Buy
Consensus Price Target
$23.67 (+626.0% Upside)
Volume
175,071 shares
Average Volume
82,071 shares
Western Copper & Gold stock logo

7. Western Copper & Gold NYSE:WRN

$1.25 -0.02 (-1.57%)
As of 07/18/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$250.94 million
P/E Ratio
-62.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+220.0% Upside)
Volume
197,366 shares
Average Volume
370,695 shares
OnKure Therapeutics stock logo

8. OnKure Therapeutics NASDAQ:OKUR

$2.33 -0.05 (-2.10%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.38 +0.05 (+1.97%)
As of 07/18/2025 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$31.48 million
P/E Ratio
-0.44
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,287.7% Upside)
Volume
131,662 shares
Average Volume
107,045 shares
Denison Mine stock logo

9. Denison Mine NYSEAMERICAN:DNN

$2.14 +0.03 (+1.42%)
Closing price 07/18/2025 04:10 PM Eastern
Extended Trading
$2.11 -0.03 (-1.40%)
As of 07/18/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.92 billion
P/E Ratio
-26.75
Consensus Rating
Buy
Consensus Price Target
$3.00 (+40.2% Upside)
Volume
79.75 million shares
Average Volume
52.77 million shares
Immunic stock logo

10. Immunic NASDAQ:IMUX

$0.96 +0.03 (+3.66%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$0.98 +0.02 (+2.18%)
As of 07/18/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$92.37 million
P/E Ratio
-0.78
Consensus Rating
Buy
Consensus Price Target
$7.50 (+678.0% Upside)
Volume
1.81 million shares
Average Volume
992,838 shares
Reviva Pharmaceuticals stock logo

11. Reviva Pharmaceuticals NASDAQ:RVPH

$0.40 -0.01 (-1.51%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$0.40 +0.00 (+0.48%)
As of 07/18/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$19.16 million
P/E Ratio
-0.51
Consensus Rating
Buy
Consensus Price Target
$9.00 (+2,155.1% Upside)
Volume
1.55 million shares
Average Volume
1.47 million shares
Quince Therapeutics stock logo

12. Quince Therapeutics NASDAQ:QNCX

$1.89 +0.06 (+3.28%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.86 -0.03 (-1.59%)
As of 07/18/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$85.94 million
P/E Ratio
-1.36
Consensus Rating
Buy
Consensus Price Target
$8.00 (+323.3% Upside)
Volume
159,826 shares
Average Volume
316,655 shares
Hochschild Mining stock logo

13. Hochschild Mining OTCMKTS:HCHDF

$3.60 +0.02 (+0.56%)
As of 07/18/2025 01:46 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$1.85 billion
Consensus Rating
Buy
Volume
6,719 shares
Average Volume
15,177 shares
Today's Range
$3.50
$3.66
50-Day Range
$3.20
$4.21
MannKind stock logo

14. MannKind NASDAQ:MNKD

$3.76 -0.14 (-3.59%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.80 +0.04 (+1.04%)
As of 07/18/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.14 billion
P/E Ratio
37.60
Consensus Rating
Buy
Consensus Price Target
$10.14 (+169.8% Upside)
Volume
2.31 million shares
Average Volume
2.43 million shares
Rezolve AI stock logo

15. Rezolve AI NASDAQ:RZLV

$2.82 -0.05 (-1.74%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.83 +0.01 (+0.35%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$587.30 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+112.8% Upside)
Volume
7.96 million shares
Average Volume
5.70 million shares
Today's Range
$2.77
$2.93
TriSalus Life Sciences stock logo

16. TriSalus Life Sciences NASDAQ:TLSI

$4.60 -0.12 (-2.54%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$4.62 +0.02 (+0.43%)
As of 07/18/2025 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$174.06 million
P/E Ratio
-4.11
Consensus Rating
Buy
Consensus Price Target
$10.75 (+133.7% Upside)
Volume
30,922 shares
Average Volume
52,525 shares
Full House Resorts stock logo

17. Full House Resorts NASDAQ:FLL

$4.71 +0.02 (+0.43%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$4.71 0.00 (0.00%)
As of 07/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$169.45 million
P/E Ratio
-4.24
Consensus Rating
Buy
Consensus Price Target
$6.00 (+27.4% Upside)
Volume
143,612 shares
Average Volume
177,603 shares
Alumis stock logo

18. Alumis NASDAQ:ALMS

$3.33 -0.18 (-5.13%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.34 +0.02 (+0.45%)
As of 07/18/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. More about Alumis

Market Capitalization
$181.17 million
Consensus Rating
Buy
Consensus Price Target
$22.86 (+586.4% Upside)
Volume
571,316 shares
Average Volume
445,130 shares
Today's Range
$3.28
$3.58
HIVE Digital Technologies stock logo

19. HIVE Digital Technologies NASDAQ:HIVE

$2.23 +0.01 (+0.45%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.26 +0.02 (+1.12%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital Technologies

Market Capitalization
$477.90 million
P/E Ratio
-6.19
Consensus Rating
Buy
Consensus Price Target
$6.67 (+199.0% Upside)
Volume
24.82 million shares
Average Volume
9.67 million shares
Vizsla Silver stock logo

20. Vizsla Silver NYSE:VZLA

$3.24 -0.05 (-1.52%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.26 +0.01 (+0.46%)
As of 07/18/2025 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vizsla Silver Corp. engages in the exploration, and development of precious and base metal assets. The company explores for gold, silver, and copper deposits. More about Vizsla Silver

Market Capitalization
$1.11 billion
P/E Ratio
-324.00
Consensus Rating
Buy
Consensus Price Target
$3.83 (+18.3% Upside)
Volume
3.98 million shares
Average Volume
2.20 million shares
Genelux stock logo

21. Genelux NASDAQ:GNLX

$3.33 -0.07 (-2.06%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.34 +0.01 (+0.30%)
As of 07/18/2025 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about Genelux

Market Capitalization
$125.74 million
P/E Ratio
-3.78
Consensus Rating
Buy
Consensus Price Target
$17.75 (+433.0% Upside)
Volume
45,235 shares
Average Volume
173,502 shares
United States Antimony stock logo

22. United States Antimony NYSE:UAMY

$3.87 +0.14 (+3.75%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.88 +0.01 (+0.39%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$460.92 million
P/E Ratio
-96.75
Consensus Rating
Buy
Consensus Price Target
$3.38 (-12.8% Downside)
Volume
11.01 million shares
Average Volume
3.03 million shares
Electrovaya stock logo

23. Electrovaya NASDAQ:ELVA

$3.69 -0.10 (-2.64%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$3.76 +0.08 (+2.03%)
As of 07/18/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electrovaya Inc engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America. More about Electrovaya

Market Capitalization
$147.99 million
Consensus Rating
Buy
Consensus Price Target
$6.10 (+65.3% Upside)
Volume
31,975 shares
Average Volume
63,682 shares
Today's Range
$3.55
$3.78
Nuvation Bio stock logo

24. Nuvation Bio NYSE:NUVB

$2.31 +0.07 (+3.13%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$2.34 +0.02 (+1.08%)
As of 07/18/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation Bio

Market Capitalization
$782.61 million
P/E Ratio
-0.98
Consensus Rating
Buy
Consensus Price Target
$7.17 (+210.2% Upside)
Volume
4.92 million shares
Average Volume
3.12 million shares
Akebia Therapeutics stock logo

25. Akebia Therapeutics NASDAQ:AKBA

$3.86 -0.02 (-0.52%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.86 0.00 (-0.13%)
As of 07/18/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akebia Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. More about Akebia Therapeutics

Market Capitalization
$1.01 billion
P/E Ratio
-18.38
Consensus Rating
Buy
Consensus Price Target
$6.75 (+74.9% Upside)
Volume
3.05 million shares
Average Volume
3.16 million shares